> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# CDER ‘Site Tours’ Program to Continue
- URL: https://www.fdaweb.com/cder-site-tours-program-to-continue/
- Published: 2017-04-25T12:00:00.000Z
- Updated: 2026-09-14T22:19:44.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5138530

*Federal Register* notice: CDER has announced its continuation of the Regulatory Project Management Site Tours and Regulatory Interaction program, and it is inviting pharmaceutical companies interested in participating to contact the Center. Under the program, CDER regulatory project managers can observe drug manufacturing and other facility operations to better understand the industry. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-04-24/pdf/2017-08183.pdf?ref=fdaweb.com).